Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer

PURPOSE: Src family kinase (SFK) proteins are frequently activated in cancer and can coordinate tumor cell growth, survival, invasion, and angiogenesis. Given the importance of SFK signaling in cancer, known cooperation between SFK and epidermal growth factor receptor (EGFR) signaling, and efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Haura, Eric B., Tanvetyanon, Tawee, Chiappori, Alberto, Williams, Charles, Simon, George, Antonia, Scott, Gray, Jhanelle, Litschauer, Sharon, Tetteh, Leticia, Neuger, Anthony, Song, Lanxi, Rawal, Bhupendra, Schell, Michael J., Bepler, Gerold
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040065/
https://ncbi.nlm.nih.gov/pubmed/20142592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados